CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will conduct 15 CE-accredited sessions in conjunction with the 15th annual Asembia Specialty Pharmacy Summit at the Wynn and Encore Hotels in Las Vegas, Nevada. The summit will be held from Monday, April 29, to Thursday, May 2, 2019.
“We are pleased once again for the opportunity to present our CE sessions to all attendees during this year’s Asembia Specialty Pharmacy Summit,” said Jim Palatine, RPh, MBA, president of PTCE. “The meeting is home to thousands of specialty pharmacy professionals, and we look forward to offering these free CE sessions to those registered for the Summit.”
The topics of PTCE’s sessions are:
- Pulmonary Arterial Hypertension, which will be held on Monday, April 29, from 11:30 a.m. to 1 p.m. This activity is supported by an education grant from Bayer HealthCare Pharmaceuticals Inc.
- Hereditary Angioedema, which will be held on Monday, April 29, from 2 p.m. to 3:30 p.m. This activity is supported by an education grant from CSL Behring.
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), which will be held on Monday, April 29, from 4:30 p.m. to 6:00 p.m. This activity is supported by an education grant from CSL Behring.
- PCSK9 Inhibitors, which will be held on Monday, April 29, from 7 p.m. to 8:30 p.m. This activity is supported by an education grant from Amgen.
- Inflammatory Bowel Disease, which will be held on Tuesday, April 30, from 7 a.m. to 8:30 a.m. This activity is supported by an education grant from Takeda Pharmaceuticals U.S.A. Inc.
- Hereditary Transthyretin Amyloidosis (hATTR), which will be held on Tuesday, April 30, from 7 a.m. to 8:30 a.m. This activity is supported by an education grant from Alnylam Pharmaceuticals Inc.
- Antiviral Treatment of Influenza, which will be held on Tuesday, April 30, from noon to 1:30 p.m. This activity is supported by an education grant from Genentech.
- Von Willebrand Disease, which will be held on Wednesday, May 1, from 7 a.m. to 8:30 a.m. This activity is supported by an education grant from Grifols.
- Peanut Allergies, which will be held on Wednesday, May 1, from 7 a.m. to 8:30 a.m. This activity is supported by an education grant from Aimmune Therapeutics.
- Idiopathic Pulmonary Fibrosis, which will be held on Wednesday, May 1, from noon to 1:30 p.m. This activity is supported by an education grant from Genentech.
- Amyotrophic Lateral Sclerosis, which will be held on Wednesday, May 1, from noon to 1:30 p.m. This activity is supported by an education grant from Mitsubishi Tanabe Pharma America, Inc.
- Diabetic Retinopathy and Diabetic Macular Edema, which will be held on Thursday, May 2, from 7 a.m. to 8:30 a.m. This activity is supported by an education grant from Genentech.
- PARP Inhibitors in Ovarian Cancer, which will be held on Thursday, May 2, from 7 a.m. to 8:30 a.m. This activity is supported by an education grant from Tesaro.
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH), which will be held on Thursday, May 2, from noon to 1:30 p.m. This activity is supported by an education grant from Actelion.
- Chronic Lymphocytic Leukemia, which will be held on Thursday, May 2, from noon to 1:30 p.m. This activity is supported by an education grant from AstraZeneca.
“Positioned at the epicenter of the industry, Asembia’s Summit is an essential event for everyone involved in specialty pharmacy,” said Robert Irene, RPh, president of Asembia. “The value-packed 2019 agenda includes a wide variety of business and educational sessions from industry experts as well as engaging exhibits and unparalleled networking events.”
Accredited by the Accreditation Council for Pharmacy Education, each PTCE session provides attendees with the opportunity to earn up to 1.5 continuing education credits. For more information and to register, click here.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE’s print, online and live CPE activities are designed to help improve the knowledge, competence and skills of pharmacists so they are better prepared to provide the highest quality of pharmacy care to the patients they serve and to the physicians they assist as part of a multidisciplinary treatment/management team. To learn more about the educational activities sponsored by PTCE, visit our website at https://www.pharmacytimes.org/.
About Asembia
Asembia works with member pharmacies, manufacturers, prescribers, payers, and other industry stakeholders to develop solutions for the high-touch specialty pharmaceutical service model. Through collaborative programs, contracting initiatives, patient support HUB services and innovative technology platforms, Asembia is committed to providing solutions that impact the patient journey. Asembia is also founder and host of the nation’s leading healthcare conference focused on increasing the quality of patient care through specialty pharmaceutical services. For more information, visit www.asembia.com.
